News & Updates
Filter by Specialty:
Show Multimedia Only

Hydroxychloroquine protects SLE patients against CV events
11 Sep 2024
Among patients with systemic lupus erythematosus (SLE), those who use of hydroxychloroquine are less likely to experience cardiovascular events, as reported in a study.
Hydroxychloroquine protects SLE patients against CV events
11 Sep 2024
Four-drug pill beats three separate meds in difficult-to-treat hypertension
07 Sep 2024
byJairia Dela Cruz
For individuals with difficult-to-treat hypertension who are struggling with three separate medications, a single pill that combines four blood pressure (BP)-lowering drugs may help with BP control, as shown in the phase III QUADRO trial.
Four-drug pill beats three separate meds in difficult-to-treat hypertension
07 Sep 2024
Paediatric T2DM: Prevalence of microalbuminuria doubles within 2 years of diagnosis
06 Sep 2024
byNatalia Reoutova
Data from the Hong Kong Childhood Diabetes Registry (HKCDR) show that 2 years after diagnosis of paediatric type 2 diabetes mellitus (T2DM), approximately 20–65 percent of patients have ≥1 of the following: microalbuminuria (MA), suboptimal glycaemic control, hypertension, or dyslipidaemia.